雖然多年來心因性休克之死亡率持續偏高，但隨著醫療維生系統的進步，心因性休克的治療方式就更為多元化。此篇文章，主要是要介紹本院近年來，用來穩定心因性休克的一種創新維生輔助系統。稱之為：經皮心肺功能維生系統(PCPS)，此系統之好處在於儀器之設計，體積輕巧、操作快速，可由心臟內科醫師，快速完成導管之放置與儀器設定，儘速建立患者之血液動力學。以提高存活率。

Mortality for refractory cardiogenic shock (CS) remains high. However, while the technology of mechanical circulatory support device advances, the treatment options for CS patients are expanding. The percutaneous cardiopulmonary support system (PCPS) as an innovative tool is used to stabilize CS in our institute. The idea behind this system is that it is small, simple and can be easily, quickly and effectively operated by cardiologists like us. (J Intern Med Taiwan 2017; 28: 213-217)